Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2011 Fourth Quarter and Year End Financial Results
Date:12/12/2011

of its commercialized products and products under development are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the risks and uncertainties associated with Avanir's operating performance and financial position, the market demand for and acceptance of Avanir's products domestically and internationally, research, development and commercialization of new products domestically and internationally, obtaining and maintaining regulatory approvals domestically and internationally, risks associated with meeting the objectives of the PRIME study, including, but not limited to, delays or failures in enrollment, and the occurrence of adverse safety events, and risks associated with initiating a study of behavioral disturbances associated with Alzheimer's disease, and other risks detailed from time to time in the Company's most recent Annual Report on Form 10-K and other documents subsequently filed with or furnished to the Securities and Exchange Commission. These forward-looking statements are based on current information that may change and you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and the Company undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.

Avanir Investor & Media Contact
Ian Clements, PhD
ir@avanir.com 
+1 (949) 389-6700AVANIR PHARMACEUTICALS, INC.CONDENSED CONSOLIDATED BALANCE SHEETS 

 

 

  September 30, September 30, 2011 201
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call
2. Avanir Pharmaceuticals to Participate in Piper Jaffray Health Care Conference
3. Avanir Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application for NUEDEXTA
4. Avanir Pharmaceuticals Submits European Marketing Authorization Application for NUEDEXTA
5. Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference
6. Avanir Pharmaceuticals to Participate in Two Investor Conferences
7. Avanir Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
8. Avanir Pharmaceuticals Files Lawsuits Against Par and Actavis for Infringement of NUEDEXTA Patents
9. Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results
10. Avanir Pharmaceuticals Announces Appointment of Dr. Joao Siffert as Senior Vice President Research and Development
11. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)...  Three-month paliperidone palmitate, an investigational atypical antipsychotic, ... in patients with schizophrenia, according to a new ... the Journal of the American Medical ... of the study served as the basis for ... three-month paliperidone palmitate injection to treat schizophrenia in ...
(Date:3/27/2015)... , March 27, 2015 Across the global ... meeting challenges in clinical development, market education, and regulatory ... the Medical Affairs function is expected to increase in ... According to research by benchmarking firm, ... a group dedicated to Medical Affairs. Among companies in ...
(Date:3/27/2015)... 27, 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" ... today announced the issuance of an aggregate of 30,000 ... and an aggregate of 120,500 stock options to employees ... vest over three years and will be exercisable for ... of $1.40 per stock option. About Covalon ...
Breaking Medicine Technology:New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 2New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 4New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 6New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 7New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 8New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 9New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 10New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 11New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 12Medical Affairs Capabilities Expanding in Emerging Marketplaces 2Covalon Announces Issuance of Stock Options 2
... Aug. 8, 2011 Systech International®, the recognized global ... leading systems engineering, automation, and manufacturing optimization services company, ... for the pharmaceutical market in Puerto Rico.  VCG now ... Systech and their extensive customer-base in region. ...
... 2011 - Pharmasset, Inc. (Nasdaq: VRUS ) announces ... to be held August 10 to 11, 2011 at the ... Executive Officer, will provide an overview of the company at ... 9:30 AM (ET). To access a simultaneous webcast ...
Cached Medicine Technology:Systech Selects Vantage Consulting Group as their Sales Agent in Puerto Rico 2Systech Selects Vantage Consulting Group as their Sales Agent in Puerto Rico 3Pharmasset to Present at Canaccord Genuity Growth Conference 2Pharmasset to Present at Canaccord Genuity Growth Conference 3
(Date:3/30/2015)... BOWLING GREEN, Ohio (PRWEB) March 30, 2015 ... , a globally recognized designer and manufacturer ... fabric and vinyl upholstery options. The new ... healthcare, laboratory, education and custom seating, providing ... upholsteries are manufactured by renowned textile purveyor ...
(Date:3/30/2015)... 30, 2015 National Nutrition Month ... their eating habits and commit to nutritious decisions that will ... According to a recent study from the U.S. Department of ... snack food. Making healthy snack choices needs to be an ... society constantly on the go. , Each day, millions of ...
(Date:3/29/2015)... 2015 At the 2015 International Health ... introduced the new Fonda wall mounted heater and ... Club owners and facilities managers with saunas smaller than ... design of the Fonda heater. With an attractive ... an immediate upgrade for a sauna, especially when mounted ...
(Date:3/29/2015)... March 30, 2015 Over 50 million ... tied to undiagnosed autoimmune, thyroid, or hormone disorders. , ... has personally treated hundreds of patients dealing with these ... of the treatment options for their ailments. Her new ... to women living with fatigue, brain fog, and sleepless ...
(Date:3/29/2015)... Orion, Clarkston, Metamora, MI. (PRWEB) March 29, 2015 ... Beaumont Hospital, offers comprehensive menopause treatment. Secondary to ... that area a closer hospital option. They continue ... and McLaren Oakland. , Menopause is a ... The term "menopause" can describe any of the changes ...
Breaking Medicine News(10 mins):Health News:BioFit Adds Bleachable Upholstery Options to Seating Line 2Health News:Benefits of Healthy Snacking — HealthyYOU Vending Machines Offer 21 Healthy Snack Selections for People on the Go 2Health News:Benefits of Healthy Snacking — HealthyYOU Vending Machines Offer 21 Healthy Snack Selections for People on the Go 3Health News:Helo Commercial Introduces Fonda Sauna Heater and Sauna and Steam Continuing Education Program at IHRSA 2Health News:How to Turn Mid-life into the Good Life 2Health News:Women's Excellence Affiliates with Beaumont Hospital, Treats Menopause 2
... the latest use of a Fab Four song in a ... anthem "All You Need Is Love" has been used to ... about the step. ,"For people who feel that ... action. You've got the Beatles, which draws like, religious feelings, ...
... Rs 3,200-crore Indian health insurance industry is poised to reach ... rate of over 44 per cent per annum, it is ... even life insurers are jumping in the fray. ... is planning to launch a health insurance product in the ...
... passed snide remarks about her, claiming that the actress is too ... Ashton Kutcher tied the knot in September 2005, and the actress ... ,Lesley Guynes, who is separated from Moores half-brother commented that the ... she was old. ,I think Demi is getting too ...
... with two felony counts of possession of a controlled substance, ... prescription and possession of marijuana, and a speeding infraction ... July 4. ,A law enforcement source revealed ... prescription drugs had been recovered from Albert Gore Thirds car. ...
... that the adverse effects of the simultaneous use of ... under-reported, and that health-care professionals and the public ... two therapies. ,Researchers at the University ... pharmacists. While 47 per cent of pharmacists reported that ...
... seems that Kate Moss has finally realised the true persona ... out of the house and getting rid of his belongings, ... ,According to pals, Moss chose the nickname because of ... substances wherever he went. ,The scornful comment ...
Cached Medicine News:Health News:Life Insurers in India to Launch Health Insurance Policies 2Health News:Side Effects of Natural Health Products With Prescription Drugs Under-reported 2
... High performance plus simple ... gentle and efficient washing ... is performed with minimum ... cells while membrane bound ...
Stat Fax 2600 is fully automatic microplate washer....
The Microtech Microplate Washer (220 V) is a flexible and ultra compact microplate washer. The system offers a wide choice of washing functions and sequences designed to handle most any microplate ap...
... a powerful, compact and programmable 2 ... vacuum and dispensing pumps. Dispense and ... vertical and horizontal needle positioning in ... wash and waste bottles and vacuum ...
Medicine Products: